Banco de Sabadell’s GSK GSK Stock Holding History

Banco de Sabadell’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-7,300	Closed	-$260K	–	80
2022 Q4	$260K	Buy	7,300 +105	+1%	+$3.5K	0.22%	59
2022 Q3	$213K	Sell	7,195 -975	-12%	-$37K	0.18%	66
2022 Q2	$443K	Sell	8,170 -220	-3%	-$12.1K	0.37%	54
2022 Q1	$456K	Buy	8,390 +568	+7%	+$30.9K	0.26%	63
2021 Q4	$433K	Buy	7,822 +660	+9%	+$34.3K	0.24%	69
2021 Q3	$343K	Sell	7,162 -428	-6%	-$21.5K	0.23%	74
2021 Q2	$375K	Buy	7,590 +498	+7%	+$23.9K	0.25%	75
2021 Q1	$319K	Sell	7,092 -1,816	-20%	-$82.4K	0.03%	186
2020 Q4	$412K	Buy	8,908 +569	+7%	+$26.1K	0.04%	192
2020 Q3	$393K	Buy	8,339 +249	+3%	+$12.5K	0.04%	236
2020 Q2	$417K	Sell	8,090 -959	-11%	-$49.2K	0.05%	181
2020 Q1	$428K	Buy	9,049 +66	+0.7%	+$3.52K	0.07%	199
2019 Q4	$526K	Sell	8,983 -286	-3%	-$15.9K	0.07%	203
2019 Q3	$498K	Sell	9,269 -199	-2%	-$10.2K	0.07%	201
2019 Q2	$473K	Sell	9,468 -1,136	-11%	-$57K	0.05%	226
2019 Q1	$559K	Sell	10,604 -1,962	-16%	-$98K	0.07%	216
2018 Q4	$604K	Sell	12,566 -3,135	-20%	-$154K	0.07%	229
2018 Q3	$786K	Sell	15,701 -237	-1%	-$12K	0.09%	217
2018 Q2	$807K	Sell	15,938 -40	-0.3%	-$2.02K	0.1%	209
2018 Q1	$780K	Buy	15,978 +1,646	+11%	+$76.7K	0.09%	247
2017 Q4	$635K	Buy	+14,332	New	+$662K	0.08%	190

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Banco de Sabadell's GSK Position: Q1 2023 in Review

Banco de Sabadell sold out of GSK (GSK) in Q1 2023, closing a stake of 7,300 shares — an estimated $260K sold.

Banco de Sabadell first reported a position in GSK in Q4 2017 and held it in 21 quarters. The position peaked at $807K in Q2 2018. 809 funds tracked by Wall St. Rank hold GSK as of Q1 2023.

Banco de Sabadell reported no remaining GSK position as of Q1 2023 after selling out during the quarter.
Banco de Sabadell sold 7,300 GSK shares in Q1 2023, an estimated $260K.
Banco de Sabadell first reported a position in GSK in Q4 2017 and held it in 21 quarters.
Banco de Sabadell's GSK position peaked at $807K in Q2 2018.
809 funds tracked by Wall St. Rank held GSK as of Q1 2023.

Based on Banco de Sabadell's 13F filing for Q1 2023, filed 12 May 2023.